Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials
- 10 August 2017
- journal article
- research article
- Published by Elsevier BV in The Lancet Diabetes & Endocrinology
- Vol. 5 (10), 788-798
- https://doi.org/10.1016/s2213-8587(17)30221-8
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Detecting Heterogeneous Treatment Effects to Guide Personalized Blood Pressure TreatmentAnnals of Internal Medicine, 2017
- Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular DiseaseAnnals of Internal Medicine, 2016
- Cardiac and Renovascular Complications in Type 2 Diabetes — Is There Hope?New England Journal of Medicine, 2016
- Tests of calibration and goodness‐of‐fit in the survival settingStatistics in Medicine, 2015
- Effect of Patients’ Risks and Preferences on Health Gains With Plasma Glucose Level Lowering in Type 2 Diabetes MellitusJAMA Internal Medicine, 2014
- Response to Comment on the Reports of Over-estimation of ASCVD Risk Using the 2013 AHA/ACC Risk EquationCirculation, 2014
- Multiple imputation using chained equations: Issues and guidance for practiceStatistics in Medicine, 2010
- Effects of Intensive Blood-Pressure Control in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusNew England Journal of Medicine, 2010
- Estimation of time‐dependent area under the ROC curve for long‐term risk predictionStatistics in Medicine, 2005